MONTREAL, QUEBEC -- (MARKET WIRE) -- October 17, 2006 -- Ambrilia Biopharma Inc. (TSX: AMB), a biopharmaceutical company developing innovative therapeutics in the fields of oncology and infectious diseases, announced today that it's President and Chief Executive Officer, Hans J. Mader, will present an overview of the Company at the BIO Investor Forum to be held in San Francisco, October 18-19. This presentation will take place on Thursday, October 19th, at 11:00 a.m. local time, in Pacific Heights room.
